Reconsidering Neuroprotection in the Reperfusion Era

Affiliations

• ¹ From the Institute for Stroke and Cerebrovascular Disease, UTHealth, Houston, TX (S.I.S.); Department of Neurology, UTHealth, Houston, TX (S.I.S.); Department of Neurology, Hôpital Sainte-Anne, University Paris Descartes, INSERM U894, France (J.-C.B.); Department of Neurology, University of California, San Francisco (M.A.Y.); Department of Neurology, San Francisco VA Medical Center, CA (M.A.Y.); Roxanna Todd Hodges Comprehensive Stroke Clinic, Los Angeles, CA (N.S.); Department of Neurology, University of Southern California, Los Angeles (N.S.); and Department of Neurology, Beth Israel Deaconess Medical Center, Boston, MA (M.F.). sean.i.savitz@uth.tmc.edu.
• ² From the Institute for Stroke and Cerebrovascular Disease, UTHealth, Houston, TX (S.I.S.); Department of Neurology, UTHealth, Houston, TX (S.I.S.); Department of Neurology, Hôpital Sainte-Anne, University Paris Descartes, INSERM U894, France (J.-C.B.); Department of Neurology, University of California, San Francisco (M.A.Y.); Department of Neurology, San Francisco VA Medical Center, CA (M.A.Y.); Roxanna Todd Hodges Comprehensive Stroke Clinic, Los Angeles, CA (N.S.); Department of Neurology, University of Southern California, Los Angeles (N.S.); and Department of Neurology, Beth Israel Deaconess Medical Center, Boston, MA (M.F.).